Intelence (etravirine) is a small molecule pharmaceutical. Etravirine was first approved as Intelence on 2008-01-18. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections.
|Drug Class||Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives|